Lineage Reprogramming: A Promising Road for Pancreatic β Cell Regeneration

Trends in Endocrinology and Metabolism

Volumn 27, Issue 3, 2016, Pages 163-176

  Wei, Rui ^a   Hong, Tianpei ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cell replacement therapy; Cell reprogramming; Diabetes mellitus; Pancreatic cells; Transdifferentiation

Indexed keywords

TRANSCRIPTION FACTOR;

ACINAR CELL; CELL REGENERATION; CELL REPROGRAMMING TECHNIQUE; CELL TRANSDIFFERENTIATION; DIABETES MELLITUS; ECTOPIC EXPRESSION; EPIGENETICS; HOST CELL; HUMAN; LIVER CELL; MICROENVIRONMENT; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; ADVERSE EFFECTS; ANIMAL; BIOLOGICAL MODEL; CELL LINEAGE; CYTOLOGY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; NUCLEAR REPROGRAMMING; PANCREAS ISLET TRANSPLANTATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; TRENDS;

ANIMALS; CELL LINEAGE; CELL TRANSDIFFERENTIATION; CELLULAR REPROGRAMMING; CELLULAR REPROGRAMMING TECHNIQUES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MODELS, BIOLOGICAL; REGENERATION;

EID: 84958119853     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2016.01.002     Document Type: Review

References (98)

1. Shapiro A.M., et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 2006, 355:1318-1330.
2. D'Amour K.A., et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
3. Wei R., et al. Insulin-producing cells derived from human embryonic stem cells: comparison of definitive endoderm- and nestin-positive progenitor-based differentiation strategies. PLoS ONE 2013, 8:e72513.
4. Pagliuca F.W., et al. Generation of functional human pancreatic beta cells in vitro. Cell 2014, 159:428-439.
5. Rezania A., et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 2014, 32:1121-1133.
6. Wabik A., Jones P.H. Switching roles: the functional plasticity of adult tissue stem cells. EMBO J. 2015, 34:1164-1179.
7. Xu X., et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell 2008, 132:197-207.
8. Jafarian A., et al. Generation of high-yield insulin producing cells from human bone marrow mesenchymal stem cells. Mol. Biol. Rep. 2014, 41:4783-4794.
9. Jiang F.X., Morahan G. Pancreatic stem cells remain unresolved. Stem Cells Dev. 2014, 23:2803-2812.
10. Houbracken I., Bouwens L. The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement. Rev. Diabet. Stud. 2010, 7:112-123.
11. Talchai C., et al. Pancreatic beta cell dedifferentiation as a mechanism of diabetic beta cell failure. Cell 2012, 150:1223-1234.
12. Wang Z., et al. Pancreatic beta cell dedifferentiation in diabetes and redifferentiation following insulin therapy. Cell Metab. 2014, 19:872-882.
13. Kayali A.G., et al. Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-producing beta-cells. Diabetes 2007, 56:703-708.
14. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
15. Katz L.S., et al. Reprogramming adult human dermal fibroblasts to islet-like cells by epigenetic modification coupled to transcription factor modulation. Stem Cells Dev. 2013, 22:2551-2560.
16. Pennarossa G., et al. Brief demethylation step allows the conversion of adult human skin fibroblasts into insulin-secreting cells. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:8948-8953.
17. Li K., et al. Small molecules facilitate the reprogramming of mouse fibroblasts into pancreatic lineages. Cell Stem Cell 2014, 14:228-236.
18. Dadheech N., et al. A small molecule swertisin from Enicostemma littorale differentiates NIH3T3 cells into islet-like clusters and restores normoglycemia upon transplantation in diabetic Balb/c mice. Evid. Based Complement. Alternat. Med. 2013, 2013:280392.
19. Mauda-Havakuk M., et al. Ectopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fate. PLoS ONE 2011, 6:e26298.
20. Nozaki T., Ohura K. Regulation of miRNA during direct reprogramming of dental pulp cells to insulin-producing cells. Biochem. Biophys. Res. Commun. 2014, 444:195-198.
21. Yin D., Tang J.G. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo. FEBS Lett. 2001, 495:16-20.
22. Mas A., et al. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes 2006, 55:1546-1553.
23. Agu C.A., et al. Successful generation of human induced pluripotent stem cell lines from blood samples held at room temperature for up to 48 hr. Stem Cell Rep. 2015, 5:660-671.
24. Chen W., et al. Skeletal myogenic differentiation of human urine-derived cells as a potential source for skeletal muscle regeneration. J. Tissue Eng. Regen. Med. 2014, Published online June 19, 2014. 10.1002/term.1914.
25. Zaret K.S., Grompe M. Generation and regeneration of cells of the liver and pancreas. Science 2008, 322:1490-1494.
26. Meivar-Levy I., et al. Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein beta. Hepatology 2007, 46:898-905.
27. Akinci E., et al. Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA. PLoS ONE 2013, 8:e82424.
28. Leite A.R., et al. Fibronectin and laminin induce expression of islet cell markers in hepatic oval cells in culture. Cell Tissue Res. 2007, 327:529-537.
29. Li Y., et al. Transdifferentiation of hepatic oval cells into pancreatic islet beta-cells. Front. Biosci. (Landmark Ed.) 2012, 17:2391-2395.
30. Liu J., et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. Sci. Rep. 2013, 3:1185.
31. Ber I., et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J. Biol. Chem. 2003, 278:31950-31957.
32. Tang D.Q., et al. Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes. Am. J. Transl. Res. 2013, 5:184-199.
33. Kojima H., et al. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 2003, 9:596-603.
34. Sapir T., et al. Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:7964-7969.
35. Thowfeequ S., et al. Reprogramming of liver to pancreas. Methods Mol. Biol. 2009, 482:407-418.
36. Aviv V., et al. Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdifferentiation process. J. Biol. Chem. 2009, 284:33509-33520.
37. Yuan Y., et al. A small-molecule inducer of PDX1 expression identified by high-throughput screening. Chem. Biol. 2013, 20:1513-1522.
38. Miyatsuka T., et al. Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. Biochem. Biophys. Res. Commun. 2003, 310:1017-1025.
39. Yechoor V., et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev. Cell 2009, 16:358-373.
40. Dutton J.R., et al. Beta cells occur naturally in extrahepatic bile ducts of mice. J. Cell Sci. 2007, 120:239-245.
41. Nagaya M., et al. Adult mouse intrahepatic biliary epithelial cells induced in vitro to become insulin-producing cells. J. Endocrinol. 2009, 201:37-47.
42. + cells in the liver to insulin-secreting ducts. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:15336-15341.
43. Banga A., et al. Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist. Gene Ther. 2014, 21:19-27.
44. Hickey R.D., et al. Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming. Stem Cell Res. 2013, 11:503-515.
45. Lee J.C., et al. Regulation of the pancreatic pro-endocrine gene neurogenin3. Diabetes 2001, 50:928-936.
46. Sumazaki R., et al. Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. Nat. Genet. 2004, 36:83-87.
47. Coad R.A., et al. Inhibition of Hes1 activity in gall bladder epithelial cells promotes insulin expression and glucose responsiveness. Biochem. Cell Biol. 2009, 87:975-987.
48. Lu Y.C., et al. Release of transgenic human insulin from gastric G cells: a novel approach for the amelioration of diabetes. Endocrinology 2005, 146:2610-2619.
49. Cheung A.T., et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000, 290:1959-1962.
50. Ahmad Z., et al. Evaluation of insulin expression and secretion in genetically engineered gut K and L-cells. BMC Biotechnol. 2012, 12:64.
51. Rasouli M., et al. Engineering an L-cell line that expresses insulin under the control of the glucagon-like peptide-1 promoter for diabetes treatment. BMC Biotechnol. 2011, 11:99.
52. Rasouli M., et al. Insulin secreted from genetically engineered intestinal cells reduces blood glucose levels in diabetic mice. Curr. Gene Ther. 2013, 13:229-239.
53. Talchai C., et al. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nat. Genet. 2012, 44:406-412.
54. Chen Y.J., et al. De novo formation of insulin-producing "neo-beta cell islets" from intestinal crypts. Cell Rep. 2014, 6:1046-1058.
55. Suzuki A., et al. Glucagon-like peptide 1 (1-37) converts intestinal epithelial cells into insulin-producing cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:5034-5039.
56. Kim S.K., et al. Notochord to endoderm signaling is required for pancreas development. Development 1997, 124:4243-4252.
57. Wang S., et al. The origin of islet-like cells in Drosophila identifies parallels to the vertebrate endocrine axis. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19873-19878.
58. Motoyoshi S., et al. Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose. Diabetologia 1998, 41:1492-1501.
59. Lipes M.A., et al. Insulin-secreting non-islet cells are resistant to autoimmune destruction. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:8595-8600.
60. Heremans Y., et al. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J. Cell Biol. 2002, 159:303-312.
61. Thule P.M., et al. Engineered insulin secretion from neuroendocrine cells isolated from human thyroid. World J. Surg. 2014, 38:1251-1261.
62. Dor Y., et al. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
63. Rankin M.M., et al. β-Cells are not generated in pancreatic duct ligation-induced injury in adult mice. Diabetes 2013, 62:1634-1645.
64. + ductal cells are multipotent progenitors throughout development but do not produce new endocrine cells in the normal or injured adult pancreas. Development 2011, 138:653-665.
65. Inada A., et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:19915-19919.
66. Sancho R., et al. Loss of Fbw7 reprograms adult pancreatic ductal cells into alpha, delta, and beta cells. Cell Stem Cell 2014, 15:139-153.
67. Swales N., et al. Plasticity of adult human pancreatic duct cells by neurogenin3-mediated reprogramming. PLoS ONE 2012, 7:e37055.
68. Hui H., et al. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 2001, 50:785-796.
69. Lefebvre B., et al. 5'-AZA induces Ngn3 expression and endocrine differentiation in the PANC-1 human ductal cell line. Biochem. Biophys. Res. Commun. 2010, 391:305-309.
70. Pan F.C., et al. Spatiotemporal patterns of multipotentiality in Ptf1a-expressing cells during pancreas organogenesis and injury-induced facultative restoration. Development 2013, 140:751-764.
71. Baeyens L., et al. Notch signaling as gatekeeper of rat acinar-to-beta-cell conversion in vitro. Gastroenterology 2009, 136:1750-1760.
72. Hesselson D., et al. Suppression of Ptf1a activity induces acinar-to-endocrine conversion. Curr. Biol. 2011, 21:712-717.
73. Zhou Q., et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455:627-632.
74. Zhang T., et al. Functional role of an islet transcription factor, INSM1/IA-1, on pancreatic acinar cell trans-differentiation. J. Cell Physiol. 2012, 227:2470-2479.
75. Lima M.J., et al. Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing beta-like cells. Diabetes 2013, 62:2821-2833.
76. Rooman I., Bouwens L. Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan. Diabetologia 2004, 47:259-265.
77. Baeyens L., et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia 2005, 48:49-57.
78. Baeyens L., et al. Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice. Nat. Biotechnol. 2014, 32:76-83.
79. Bramswig N.C., et al. Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming. J. Clin. Invest. 2013, 123:1275-1284.
80. Rorsman P., et al. K(ATP)-channels and glucose-regulated glucagon secretion. Trends Endocrinol. Metab. 2008, 19:277-284.
81. Bosco D., et al. Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 2010, 59:1202-1210.
82. Habener J.F., Stanojevic V. α-Cell role in β-cell generation and regeneration. Islets 2012, 4:188-198.
83. Yang Y.P., et al. Context-specific alpha- to-beta-cell reprogramming by forced Pdx1 expression. Genes Dev. 2011, 25:1680-1685.
84. Collombat P., et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells. Cell 2009, 138:449-462.
85. Al-Hasani K., et al. Adult duct-lining cells can reprogram into beta-like cells able to counter repeated cycles of toxin-induced diabetes. Dev. Cell 2013, 26:86-100.
86. Courtney M., et al. The inactivation of Arx in pancreatic alpha-cells triggers their neogenesis and conversion into functional beta-like cells. PLoS Genet. 2013, 9:e1003934.
87. Fomina-Yadlin D., et al. Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15099-15104.
88. Fomina-Yadlin D., et al. GW8510 increases insulin expression in pancreatic alpha cells through activation of p53 transcriptional activity. PLoS ONE 2012, 7:e28808.
89. Thorel F., et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature 2010, 464:1149-1154.
90. Chung C.H., et al. Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Stem Cells 2010, 28:1630-1638.
91. Chera S., et al. Diabetes recovery by age-dependent conversion of pancreatic delta-cells into insulin producers. Nature 2014, 514:503-507.
92. Negi S., et al. Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS ONE 2012, 7:e30415.
93. Russ H.A., et al. Insulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitro. PLoS ONE 2011, 6:e25566.
94. Bar Y., et al. Redifferentiation of expanded human pancreatic beta-cell-derived cells by inhibition of the NOTCH pathway. J. Biol. Chem. 2012, 287:17269-17280.
95. Landsman L., et al. Elevated Hedgehog/Gli signaling causes beta-cell dedifferentiation in mice. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17010-17015.
96. Zhang Y., et al. Small molecules, big roles - the chemical manipulation of stem cell fate and somatic cell reprogramming. J. Cell Sci. 2012, 125:5609-5620.
97. Anokye-Danso F., et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 2011, 8:376-388.
98. Zhao Y., et al. A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming. Cell 2015, 163:1678-1691.